FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                       
1. Name and Address of Reporting Person * Fitzgerald Trae 2. Issuer Name and Ticker or Trading Symbol VIEMED HEALTHCARE, INC. [ VMD ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Financial Officer
(Last)          (First)          (Middle)
625 E. KALISTE SALOOM RD.		 3. Date of Earliest Transaction (MM/DD/YYYY)
5/9/2022
(Street)
LAFAYETTE, LA 70508
(City)        (State)        (Zip)
 4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
 6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares  5/9/2022    M    1337  A  (1) 54638  D   
Common Shares  5/9/2022    D    1337  D $5.26  53301  D   
Common Shares  5/9/2022    M    1087  A  (1) 54388  D   
Common Shares  5/9/2022    D    1087  D $5.26  53301  D   
Common Shares  5/9/2022    M    1158  A  (1) 54459  D   
Common Shares  5/9/2022    D    1158  D $5.26  53301  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Share Units   (2) 5/9/2022    M        1337    (3) 5/9/2022  Common Shares  1337.0  $0  0  D   
Phantom Share Units   (2) 5/9/2022    M        1087    (4) 5/9/2023  Common Shares  1087.0  $0  1087  D   
Phantom Share Units   (2) 5/9/2022    M        1158    (5) 5/9/2024  Common Shares  1158.0  $0  2314  D   

Explanation of Responses:
(1)  Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one share of the Company's common shares. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
(2)  Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
(3)  Represents an award granted in 2019 under the Issuer's Phantom Share Unit Plan which vests on May 9, 2022, subject to the Reporting Person's continued employment with the Issuer on such vesting date.
(4)  Represents an award granted in 2020 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2022 and May 9, 2023, subject to the Reporting Person's continued employment with the Issuer on such vesting date.
(5)  Represents an award granted in 2021 under the Issuer's Phantom Share Unit Plan which vests in equal installments on May 9, 2022, May 9, 2023, and May 9, 2024, subject to the Reporting Person's continued employment with the Issuer on such vesting date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Fitzgerald Trae
625 E. KALISTE SALOOM RD.
LAFAYETTE, LA 70508

Chief Financial Officer

Signatures
/s/ Trae Fitzgerald 5/10/2022
**Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Jan 2023 to Feb 2023 Click Here for more VieMed Healthcare Charts.
VieMed Healthcare (NASDAQ:VMD)
Historical Stock Chart
From Feb 2022 to Feb 2023 Click Here for more VieMed Healthcare Charts.